Weight loss injections like semaglutide (Wegovy) and tirzepatide (Zepbound) have transformed obesity treatment, yet some patients experience disappointing results despite proper use
Turton MD, OShea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, et al
Breastfeeding individuals should also avoid GLP-1 medications, as it remains unknown whether these peptides transfer into breast milk or how they might affect nursing infants
Beinaglutide demonstrated significant advantages in weight reduction, but no significant differences were observed between the two groups in terms of improvements in liver stiffness, HbA1c control, liver enzymes, and blood lipids